Although we did not assess these molecular pathways directly, future studies incorporating HIF expression, VEGF levels, and oxidative stress biomarkers are warranted to determine causality and further elucidate the molecular interplay between OSA and urinary tract malignancies. This evidence concerns the gene VEGFA and obstructive sleep apnea syndrome.